CN112841640A - Edible black ant health-care beverage or food and preparation method thereof - Google Patents
Edible black ant health-care beverage or food and preparation method thereof Download PDFInfo
- Publication number
- CN112841640A CN112841640A CN202110018849.1A CN202110018849A CN112841640A CN 112841640 A CN112841640 A CN 112841640A CN 202110018849 A CN202110018849 A CN 202110018849A CN 112841640 A CN112841640 A CN 112841640A
- Authority
- CN
- China
- Prior art keywords
- ant
- edible
- powder
- health
- black
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 25
- 235000013305 food Nutrition 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 46
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000013339 cereals Nutrition 0.000 claims abstract description 15
- 239000003610 charcoal Substances 0.000 claims abstract description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 12
- 244000302661 Phyllostachys pubescens Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000013402 health food Nutrition 0.000 claims abstract description 10
- 241000371652 Curvularia clavata Species 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 9
- 235000009566 rice Nutrition 0.000 claims abstract description 9
- 240000007594 Oryza sativa Species 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 16
- 239000006187 pill Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 241000209094 Oryza Species 0.000 claims description 8
- 241000257303 Hymenoptera Species 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- 238000004806 packaging method and process Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- NGWKGSCSHDHHAJ-YPFQVHCOSA-N Liquoric acid Chemical compound C1C[C@H](O)C(C)(C)C2CC[C@@]3(C)[C@]4(C)C[C@H]5O[C@@H]([C@](C6)(C)C(O)=O)C[C@@]5(C)[C@@H]6C4=CC(=O)C3[C@]21C NGWKGSCSHDHHAJ-YPFQVHCOSA-N 0.000 claims description 4
- NGWKGSCSHDHHAJ-UHFFFAOYSA-N Liquoric acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CC5OC(C(C6)(C)C(O)=O)CC5(C)C6C4=CC(=O)C3C21C NGWKGSCSHDHHAJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000000643 oven drying Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 241001251068 Formica fusca Species 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 9
- 208000007536 Thrombosis Diseases 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 7
- 208000006011 Stroke Diseases 0.000 abstract description 7
- 230000002490 cerebral effect Effects 0.000 abstract description 7
- 208000029078 coronary artery disease Diseases 0.000 abstract description 7
- 201000001421 hyperglycemia Diseases 0.000 abstract description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract description 6
- 235000019253 formic acid Nutrition 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 239000003755 preservative agent Substances 0.000 abstract description 4
- 230000002335 preservative effect Effects 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 230000018109 developmental process Effects 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 2
- 238000004140 cleaning Methods 0.000 abstract description 2
- 231100000167 toxic agent Toxicity 0.000 abstract description 2
- 239000003440 toxic substance Substances 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 10
- 206010016256 fatigue Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000036299 sexual function Effects 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001330002 Bambuseae Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001251094 Formica Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010048222 Xerosis Diseases 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- -1 compound Adenosine Triphosphate Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3472—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
- C12G3/06—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Obesity (AREA)
- Insects & Arthropods (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
Abstract
The invention discloses an edible black ant health-care beverage or food and a preparation method thereof, wherein the health-care beverage is prepared from the following raw materials: ant juice accounting for 20% of the total volume of the beverage per 100 ml, 60-degree pure grain liquor accounting for 25% of the total volume of the beverage per 100 ml, and citric acid juice or purified water accounting for 55% of the total volume of the beverage per 100 ml. The health food is prepared from the following raw materials: the food comprises 50% of black ant powder, 35% of black rice powder, 12% of glutinous rice powder and 3% of edible bamboo charcoal powder. The health-care beverage and food can assist in regulating precordial stabbing pain caused by hypertension, hyperglycemia, thrombus, cerebral apoplexy and coronary heart disease; health preserving and health preserving: balancing nutrition, balancing organism, cleaning intestine and stomach, removing toxic substance, caring skin, improving endurance, enhancing immunity, relieving fatigue, invigorating qi, promoting teenager development, and resisting aging and prolonging life for the middle aged and the elderly; the formic acid is a strong preservative and does not need to be added with the preservative.
Description
Technical Field
The invention relates to the field of health care products, in particular to an edible black ant health care beverage or food and a preparation method thereof.
Background
The formic acid and the formic aldehyde are the general term of the ant liquid juice, and have larger nasal acid; the ant contains the components of formic acid, formil, protein content as high as 42-67%, 19 enzymes and coenzymes, 28 free amino acids, growth hormone and interferon, wherein 8 necessary amino acids are complete, the formic acid and ant powder contain high-energy phosphorus-containing compound Adenosine Triphosphate (ATP), and contains various trace elements necessary for human bodies, such as selenium, manganese, zinc, phosphorus, calcium and other mineral substances, various vitamins, such as B1, B2, B12, A, C, D, E and various alkaloids, the zinc element content of the ant is the highest, each kilogram of ant contains 230-280 mg of zinc, and the components are necessary for resisting rheumatism, resisting inflammation, protecting liver, easing pain and inhibiting tumors, and the high zinc property of the ant is a valuable component for treating serious zinc deficiency and rheumatoid arthritis.
The ant can be used as medicine for curing diseases, also can be used as food for supplementing various nutrient components for human body. The product can supplement nutrition, improve intelligence and memory, promote body development, and increase height of children, and can be used for caring skin, whitening skin, caring skin, removing speckle, and regulating gynecological diseases; the product is suitable for men to invigorate yang, strengthen kidney, improve sexual function, prolong life, improve immunity, strengthen body constitution, prevent common cold, invigorate energy, promote natural movement of hands and feet, stimulate appetite, and stabilize sleep.
Practice proves that: formic acid and formic aldehyde are effective enhancers for bidirectional regulation of immune system and enhancement of immunity, and are anti-aging agents, sexual function enhancers, and immunomodulators. After a certain dosage is taken, the nutritional status of the whole body can be improved, yin and yang of the human body can be balanced, qi and blood can be regulated, and the special effects of health care and health preservation can be exerted. The ants can be taken for a long time, and few individuals may have uncomfortable phenomena after taking the ants; therefore, the invention designs a health-care beverage and food which take ants as raw materials.
Disclosure of Invention
The health-care product obtained by the preparation method has the antiseptic function of the raw materials, can bidirectionally regulate deficiency and difficulty, assists in regulating hypertension, hyperglycemia, thrombus, cerebral apoplexy and coronary heart disease, and improves body immunity.
In order to solve the technical problems, the invention adopts the following technical scheme:
the invention provides an edible black ant health-care drink which is characterized by being prepared from the following raw materials: ant juice accounting for 20% of the total volume of the beverage per 100 ml, 60-degree pure grain liquor accounting for 25% of the total volume of the beverage per 100 ml, and citric acid juice or purified water accounting for 55% of the total volume of the beverage per 100 ml.
The invention provides an edible black ant health food, which is characterized by being prepared from the following raw materials: the food comprises 50% of black ant powder, 35% of black rice powder, 12% of glutinous rice powder and 3% of edible bamboo charcoal powder.
The invention also relates to a preparation method of the edible black ant health-care drink, which is characterized by comprising the following specific steps:
1) squeezing edible black ant to obtain ant juice, taking out 60% (v/v) pure grain wine, and making into liquor, and lemon acid juice or purified water;
2) blending the ant juice obtained in the step 1 with 60-degree pure grain liquor and citric acid juice, mixing and stirring to obtain a health-care beverage or blending the ant juice with 60-degree pure grain liquor and purified water, mixing and stirring to obtain a health-care beverage;
3) and (3) filling the health-care drink obtained in the step (2) into an oral liquid bottle, and sterilizing and packaging to form a product.
The invention also relates to a preparation method of the edible black ant health food, which is characterized by comprising the following specific steps:
1) oven drying the residue of ant skin after squeezing to obtain black ant powder; pulverizing fructus Zizaniae Caduciflorae into powder, and edible bamboo charcoal powder and Oryza Glutinosa powder;
2) mixing the black ant powder and the black rice powder in the step 1 with the edible bamboo charcoal powder and stirring;
3) adding water into the glutinous rice flour, decocting into paste, stirring with the mixture obtained in the step (2) to form dough, putting into a pill making machine, processing into small edible pills with the diameter of 6-12 mm, drying, sterilizing, and drying to remove water;
4) and (4) filling the edible pills obtained in the step (3) into a special food bottle, adding a water-absorbing drying bag, and sealing and packaging to form a product.
Preferably, the edible black ants are large-grain fresh wet ants;
preferably, the fineness of the black ant powder is 500 meshes;
preferably, the fineness of the black rice flour, the edible bamboo charcoal powder and the glutinous rice powder is more than 500 meshes.
The taking method comprises the following steps: the traditional Chinese medicine is orally taken.
The invention has the beneficial effects that: 1. assisting in regulating precordial pain caused by hypertension, hyperglycemia, thrombus, cerebral apoplexy and coronary heart disease; 2. health preserving and health preserving: balancing nutrition, balancing organism, cleaning intestine and stomach, removing toxic substance, caring skin, improving endurance, enhancing immunity, relieving fatigue, invigorating qi, promoting teenager development, and resisting aging and prolonging life for the middle aged and the elderly; 3. the formic acid is a strong preservative and does not need to be added with the preservative.
The beneficial effects of the invention are further explained by combining the main components in the invention as follows:
bamboo charcoal powder: has the efficacy of clearing stomach: according to the record of the traditional Chinese medicine, the stomach can be cleared, the toxin can be removed, harmful substances can be absorbed and discharged out of the body, the maladaptive symptoms caused by belly pulling can be adjusted, and the odor in excrement can be inhibited; provide proliferation of weakly acidic bacteria in the intestine and decrease harmful bacteria; providing negative ions, which can inhibit the production of active enzymes caused by diseases; can enhance the immunity of human bodies: contains nutrient components such as potassium, calcium, sodium, etc., and enzyme related to immune function in mineral form can enhance immunity; toxin expelling and face nourishing: it can be used for treating skin injury such as xerosis cutis and pruritus due to skin allergy or infection.
Formica acid and Ant Roots Ant aldehyde: the product has warm and tonic properties, and sour and slightly salty taste, and has effects of regulating body resistance, strengthening body resistance, prolonging life, invigorating kidney, tonifying yang, nourishing blood, tranquilizing mind, strengthening tendons and bones, dispelling pathogenic wind, removing dampness, caring skin, protecting liver, relieving asthma and cough, promoting hair growth, blackening hair, enhancing immunity, relieving fatigue, invigorating qi, enhancing sexual function, and improving sleep.
Detailed Description
The technical solutions of the present invention will be described clearly and completely in the following embodiments of the present invention, and it should be understood that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without any inventive step based on the embodiments of the present invention, are within the scope of the present invention.
Example 1
An edible black ant health-care drink is prepared from the following raw materials: 20 ml of ant juice, 25 ml of 60-degree pure grain liquor and 55 ml of citric acid extract.
The preparation method of the health-care beverage comprises the following steps:
1) squeezing edible black ant to obtain ant juice, and taking out 60% (v/v) pure grain liquor and citric acid juice;
2) blending and mixing the ant juice obtained in the step 1 with 60-degree pure grain liquor and citric acid juice, and stirring to obtain a health-care beverage;
3) and (3) filling the health-care drink obtained in the step (2) into an oral liquid bottle, and sterilizing and packaging to form a product.
Example 2
An edible black ant health-care drink is prepared from the following raw materials: 20 ml of ant juice, 25 ml of 60-degree pure grain wine and 55 ml of purified water.
The preparation method of the health-care beverage comprises the following steps:
1) squeezing edible black ant to obtain liquid juice, taking out 60 degree pure grain liquor, and pure water;
2) blending and mixing the ant juice obtained in the step 1 with 60-degree pure grain liquor and purified water to obtain a health-care beverage;
3) and (3) filling the health-care drink obtained in the step (2) into an oral liquid bottle, and sterilizing and packaging to form a product.
Example 3
An edible black ant health food is prepared from the following raw materials:
500 g of black ant powder, 350 g of black rice powder, 120 g of glutinous rice powder and 30 g of edible bamboo charcoal powder.
The preparation method of the health food comprises the following steps:
1) oven drying the residue of ant skin after squeezing to obtain black ant powder; pulverizing fructus Zizaniae Caduciflorae into powder, and edible bamboo charcoal powder and Oryza Glutinosa powder;
2) mixing the black ant powder and the black rice powder in the step 1 with the edible bamboo charcoal powder and stirring;
3) adding water into glutinous rice flour, decocting into paste, stirring with the mixture obtained in the step (2) to obtain dough, putting into a pill making machine, processing into small edible pills with the diameter of 6mm, drying, sterilizing, and drying to remove water;
4) and (4) filling the edible pills obtained in the step (3) into a special food bottle, adding a water-absorbing drying bag, and sealing and packaging to form a product.
Clinical trials applying the present invention:
300 patients, wherein 150 male patients, 150 female patients, age 15-70 years old, 50 hypertension patients, 50 hyperglycemia patients, 50 thrombus patients, 50 cerebral apoplexy patients, 50 coronary heart disease patients, 50 insomnia and dreaminess patients, 300 patients are divided into 5 groups, and the 5 groups are similar as much as possible to have comparability.
The treatment method comprises the following steps: one pill of health food is taken in the morning and evening every day, and 5 ml of health beverage is taken at noon. Observed after 2 months.
Diagnostic criteria
The method has the following advantages: a decrease in blood pressure in hypertensive patients; hyperglycemia patients have reduced blood glucose; the thrombus blockage phenomenon of a thrombus patient is reduced; the phenomena of dizziness and the like of the cerebral apoplexy patient are reduced; the precordial pricking pain phenomenon of the patient with coronary heart disease is reduced; patients with lassitude, insomnia and dreaminess have good mental status and red complexion.
As a result:
example 1 taken in conjunction with example 3: 49 patients with hypertension in 50 cases are effective, and the effective rate is 98%; 48 effective patients with 50 hyperglycemia, and the effective rate is 96%; 50 patients with thrombus are effective in 48 patients, and the effective rate is 96%; 48 effective patients with 50 cerebral apoplexy patients have an effective rate of 96 percent; 49 patients with coronary heart disease have the efficacy, and the effective rate is 98%; 50 effective patients with lassitude, insomnia and dreaminess have the effective rate of 100 percent.
Example 2 taken in conjunction with example 3: 50 patients with hypertension have 48 effective parts, and the effective rate is 96%; 50 patients with hyperglycemia have 50 effective parts, and the effective rate is 100 percent; 49 effective patients with 50 cases of thrombus, and the effective rate is 98%; 46 effective patients with 50 cerebral apoplexy patients have an effective rate of 92 percent; 48 patients with coronary heart disease have the efficacy of 50 patients, and the effective rate is 96%; 50 effective patients with lassitude, insomnia and dreaminess have the effective rate of 100 percent.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such modifications and variations of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is also intended to include such modifications and variations.
Claims (7)
1. An edible black ant health-care drink is characterized by being prepared from the following raw materials: ant juice accounting for 20% of the total volume of the beverage per 100 ml, 60-degree pure grain liquor accounting for 25% of the total volume of the beverage per 100 ml, and citric acid juice or purified water accounting for 55% of the total volume of the beverage per 100 ml.
2. A preparation method of an edible black ant health-care drink is characterized by comprising the following specific steps:
1) squeezing edible Formica Fusca to obtain ant juice, taking out 60% (v/v) pure grain liquor, and making into wine, and keeping citric acid juice or purified water;
2) blending and mixing the ant juice obtained in the step 1 with 60-degree pure grain liquor and citric acid juice to obtain a health-care beverage or blending and mixing the ant juice with 60-degree pure grain liquor and purified water to obtain a health-care beverage;
3) and (3) filling the health-care drink obtained in the step (2) into an oral liquid bottle, and sterilizing and packaging to form a product.
3. The method as claimed in claim 2, wherein the edible black ants in step 1 are large-sized fresh wet ants.
4. An edible black ant health food is characterized by being prepared from the following raw materials: the food comprises 50% of black ant powder, 35% of black rice powder, 12% of glutinous rice powder and 3% of edible bamboo charcoal powder.
5. The edible black ant health food as claimed in claim 4, wherein the fineness of the black ant powder is 500 meshes.
6. The edible black ant health food as claimed in claim 4, wherein the fineness of the black rice powder, the edible bamboo charcoal powder and the glutinous rice powder is above 500 meshes.
7. A preparation method of edible black ant health food is characterized by comprising the following specific steps:
1) oven drying the residue of ant skin after squeezing to obtain black ant powder; pulverizing fructus Zizaniae Caduciflorae into powder, and edible bamboo charcoal powder and Oryza Glutinosa powder;
2) mixing the black ant powder and the black rice powder in the step 1 with the edible bamboo charcoal powder and stirring;
3) adding water into glutinous rice flour, decocting into paste, mixing with the mixture obtained in step 2, stirring into dough, adding into pill making machine, processing into small edible pills with diameter of 6-12 mm,
drying and sterilizing, and drying to remove water;
4) and (4) filling the edible pills obtained in the step (3) into a special food bottle, adding a water absorption drying bag, and sealing and packaging to form a product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110018849.1A CN112841640A (en) | 2021-01-07 | 2021-01-07 | Edible black ant health-care beverage or food and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110018849.1A CN112841640A (en) | 2021-01-07 | 2021-01-07 | Edible black ant health-care beverage or food and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112841640A true CN112841640A (en) | 2021-05-28 |
Family
ID=76004825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110018849.1A Pending CN112841640A (en) | 2021-01-07 | 2021-01-07 | Edible black ant health-care beverage or food and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112841640A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101283826A (en) * | 2008-05-16 | 2008-10-15 | 李育成 | Ant beverage formulation and production method thereof |
| CN112168869A (en) * | 2020-11-13 | 2021-01-05 | 李树高 | Formic acid traditional Chinese medicine and preparation method thereof |
-
2021
- 2021-01-07 CN CN202110018849.1A patent/CN112841640A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101283826A (en) * | 2008-05-16 | 2008-10-15 | 李育成 | Ant beverage formulation and production method thereof |
| CN112168869A (en) * | 2020-11-13 | 2021-01-05 | 李树高 | Formic acid traditional Chinese medicine and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105211863A (en) | A kind of composition and mountain, ginger jujube Huaihe River ferment thereof making mountain, ginger jujube Huaihe River ferment | |
| CN102224891A (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN115736142A (en) | Formula and preparation process of prebiotics prune fiber fruit drink | |
| CN101828738B (en) | Health care beverage for preventing and treating diabetes mellitus | |
| CN103238889B (en) | Anti-fatigue apple vinegar health beverage and preparation method thereof | |
| CN105255637B (en) | A kind of health preserving wine and its brew method | |
| CN108323600A (en) | A kind of health care ferment tea solid electuary and its production method | |
| CN102228117A (en) | Chicory tea | |
| CN105029553A (en) | Fruit juice-egg-calcium traditional Chinese medicine health beverage and preparation method thereof | |
| CN110859904A (en) | Gorgon fruit oral liquid capable of tonifying kidney, supporting yang, tonifying qi and producing sperm | |
| KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
| CN110915970A (en) | Traditional Chinese medicine tablet candy capable of reducing urate deposition and preparation method thereof | |
| CN112273490A (en) | Hawthorn and ginger tea potion | |
| CN112841640A (en) | Edible black ant health-care beverage or food and preparation method thereof | |
| CN107897621A (en) | A kind of abalone effervescent tablet production method | |
| CN112168869A (en) | Formic acid traditional Chinese medicine and preparation method thereof | |
| CN114191515A (en) | Oral gel for dispelling dampness, invigorating stomach and improving immunity and preparation method thereof | |
| KR101391713B1 (en) | Salad dressing composition | |
| KR20210084942A (en) | The manufacturing method of making healthcare food composition for costitutional group | |
| KR20030036434A (en) | Healthy food product using comi fructus as main ingredient | |
| CN106234888A (en) | A kind of cherry tomato Herba Passiflorae Caeruleae mulse and preparation method thereof | |
| CN115176949A (en) | Pear juice health-care beverage and preparation method thereof | |
| CN110150517A (en) | A kind of clearing heat and detoxicating plant beverage formula and processing technology | |
| CN114931215A (en) | Medicated food product for preventing and treating chronic gastritis and processing method thereof | |
| CN111728187A (en) | Whitebait sauce and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210528 |